Clinical Validation of the Astarte® Blend
Vaginal microflora is a complex and dynamic organization that supports a layered defense system and is dominated by only several Lactobacilli in approximately 70% of women. Jarro-Dophilus® Women is an important development in women’s health because it uniquely contains the four patented and clinically documented Astarte strains, which are the actual predominant species found in the vaginal tract of healthy women. Multiple, high-quality clinical studies have demonstrated that the strains in Astarte® are an effective choice for vaginal health.
Protected by U.S. Patent 8,846,027 and European Patent 2,509,610, which are owned by HSO Health Care GmbH, Vienna, Austria, and licensed in the U.S. to Jarrow Formulas, Inc. Other international patents pending. Sold worldwide as Astarte.